AMNEAL PHARMACT Cash Flow - Quarterly (NYSE:AMRX)

Add to My Stocks
$17.29 $0.24 (1.41%) AMRX stock closing price Jun 22, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-130.93M-469.28M-168.21M-118.84M-98.43M-472.03M-192.44M-13.1M-10.4M38.99M
Depreciation Depletion Amortization Cash-Flow17.97M109.44M85.37M53.96M25.75M88.34M63.1M36.41M15.72M68.63M
Net Increase (Decrease) in Assets Liabilities18.04M-11.11M-18.07M22.65M20.69M-2.43M-22.25M-11.65M44.28M-70.18M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net9.42M455.17M147.72M100.41M91.79M460.71M249.37M12.12M27.86M34.47M
Net Cash from (used by) Operating Activities
-85.48M84.22M46.8M58.19M39.8M74.59M97.76M23.78M77.45M71.92M
Increase (Decrease) in Prop Plant And Equipment-3.95M-17.63M-15.07M-18.64M-8.67M-48.04M-30.51M-19.16M-10.88M-25.19M
Acquisition Disposition of Subsidiaires--0.12M----585.8M-585.8M---691.34M
Increase (Decrease) in Investments--4.22M----4.75M---195.31M
Other Cash Inflow (Outflow) from Investment Activities17.75M12.3M11.85M11.85M-11.5M11.5M11.5M-3.5M53.69M
Net Cash from (used by) Investment Activities
13.79M-9.68M-2.69M-6.26M-8.15M-627.09M-604.81M-7.66M-14.38M-467.53M
Issuance (Purchase) of Equity Shares-1.37M---9.23M9.13M9.17M7.66M99.79M
Issuance (Repayment) of Debt Securities-5M-70M-65M-60M-55M395M400M--600M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.98M-5.04M-3.48M-2.7M-1.26M-12.45M-11.36M---178.4M
Net Cash from (used by) Financing Activities
-5.47M-73.67M-67.63M-62.11M-56.09M391.78M397.77M9.71M8.1M521.38M
Effect of Exchange Rate Changes on Cash-0.42M-1.04M1.45M1.56M-1.04M---0.29M
Net Change in Cash & Cash Equivalents
-77.58M1.64M-22.47M-8.73M-22.88M-160.21M-108.22M26.49M71.82M125.47M
Cash & Equivalents at Beginning of Year180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M37.46M
Cash & Equivalents at Year End104.19M181.77M157.65M171.39M157.25M180.13M232.12M366.84M412.17M340.35M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Key Financial Ratios For AMNEAL PHARMACT Cash Flow